Position in BMY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,465,444
-$333,553 QoQ
Shares Held
42,788
-7.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#750
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Choate Investment Advisors holds $157,042,184 across 12 Drug Manufacturers - General names. BMY ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,791 | $60,920,254 | |
| 2 | JNJ |
Johnson & Johnson
|
184,823 | $46,939,497 | |
| 3 | ABBV |
AbbVie Inc.
|
71,634 | $18,025,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,736 | $12,173,576 | |
| 5 | NVS |
Novartis AG
|
29,237 | $4,582,022 | |
| 6 | AMGN |
Amgen Inc
|
12,190 | $4,414,242 | |
| 7 | PFE |
Pfizer Inc
|
142,810 | $3,438,864 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
42,788 | $2,465,444 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,465,444 | 42,788 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,798,997 | 46,150 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,418,453 | 44,836 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,082,582 | 46,177 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,170,260 | 46,884 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,773,703 | 45,478 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,634,904 | 46,586 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,434,884 | 47,060 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,761,121 | 42,406 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,443,766 | 45,063 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,465,907 | 48,059 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,723,585 | 46,926 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $2,348,435 | 36,723 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $2,262,139 | 32,638 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,307,292 | 32,068 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,368,150 | 33,312 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,479,400 | 32,200 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,417,219 | 33,099 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $2,143,904 | 34,385 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,173,136 | 36,727 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $2,609,855 | 39,058 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $2,771,091 | 43,895 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,703,143 | 43,578 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,859,192 | 47,424 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $3,099,112 | 52,706 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $3,020,996 | 54,198 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||